Pachychoroid Spectrum Disorder Findings in Patients with Coronavirus Disease 2019

Purpose. To report the occurrence of acute, bilateral, central serous chorioretinopathy (CSC), and pachychoroid spectrum disorder findings in patients with coronavirus disease 2019 (COVID-19). Methods. In recovered cases of COVID-19 with visual disturbances, complete ocular examinations with multimo...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in ophthalmological medicine 2021-09, Vol.2021, p.4688764-9
Main Authors: Abrishami, Mojtaba, Daneshvar, Ramin, Shoeibi, Nasser, Saeedian, Neda, Heidarzadeh, Hamid Reza, Hosseini, Seyedeh Maryam
Format: Article
Language:English
Subjects:
Cancer
Care and treatment
Case reports
Case Series
Coronaviruses
COVID-19
Diagnostic imaging
Disease
Fluorescence
Inflammation
Medical imaging
Medical research
Medical screening
Medicine, Experimental
Patients
Photochemotherapy
Retina
Retinal detachment
Severe acute respiratory syndrome coronavirus 2
Steroids
Stress (Psychology)
Verteporfin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose. To report the occurrence of acute, bilateral, central serous chorioretinopathy (CSC), and pachychoroid spectrum disorder findings in patients with coronavirus disease 2019 (COVID-19). Methods. In recovered cases of COVID-19 with visual disturbances, complete ocular examinations with multimodal retinal and choroidal evaluation, including enhanced depth imaging optical coherence tomography, fluorescein or indocyanine green angiography, and blue autofluorescence, were obtained. Results. Four COVID-19 recovered patients presented with bilateral blurred vision. Ocular examination and imaging revealed pachychoroid and pachyvessels associated with choroidal hyperpermeability without any obvious intraocular inflammation. Bilateral localized serous retinal detachment was obvious in three cases compatible with pachychoroid associated with CSC manifestation and pachychoroid pigment epitheliopathy in one patient. CSC was resolved with treatment by steroidal antimineralocorticoid (Eplerenone) in two patients and by photodynamic therapy in one patient. None of the patients reported emotional stress and history of corticosteroid consumption. Conclusion. Hyperpermeability of the choroid, pachychoroidopathy, or choroidal vessel congestion can be observed or exacerbated in association with COVID-19.
ISSN:2090-6722
2090-6730
DOI:10.1155/2021/4688764